Genetic Toxicology Testing Market by Product (Assays, Reagents & Consumables, Services), By Application (Healthcare Industry, Food Industry, Cosmetics Industry, Agriculture Industry), COVID-19 Impact – Global Forecast to 2025
The genetic toxicology testing market is projected to reach USD 2.0 billion by 2025 from USD 1.2 billion in 2020, at a CAGR of 10.2%. Growth in this market is primarily driven by increased pharmaceutical research activities, opposition to animal testing, and R&D on early toxicity detection. The increasing focus on drug discovery and personalized medicine using in vitro methods, and the rising demand for humanized animal models, is expected to offer significant growth opportunities for the players operating in the global genetic toxicology services market. On the other hand, the failure to establish the intricacies of in vivo conditions, lack of in vitro models to study complex endpoints, and the reluctance of regulatory authorities to consider alternative methods for proving safety and efficacy are expected to restrain the growth of this market to a certain extent.
Based on product, the services segment holds the largest market share during the forecast period.
Based on product, the genetic toxicology testing market is segmented into reagents & consumables, assays, and services. The services segment accounted for the larger market share in 2019. The growing R&D activities in the pharmaceutical industry, growing government investments in the field of life sciences research, and the increasing research being undertaken with integrated omics studies, which is leading to increased outsourcing of services to contract research organizations (CROs), are factors attributing to the larger share of the segment.
Based on application, the cosmetics industry segment is expected to register the highest CAGR during the forecast period.
Based on application, the genetic toxicology testing market is segmented into the healthcare industry (pharmaceutical & biotechnology), food industry, cosmetic industry, and others (agriculture and chemical industries). The cosmetics industry segment is expected to witness the highest growth during the forecast period. The increasing use of cosmetics owing to the rising disposable incomes and their easy availability to the public has driven the industry to invest in the research of breakthrough products and develop safe products are set to drive market growth.
North America is expected to account for the largest share of the genetic toxicology testing market in 2019
In 2019, North America accounted for the largest share of the genetic toxicology testing market, followed by Europe, the Asia Pacific, Latin America, and the Middle East & Africa. The large share of this market segment can be attributed to the increasing development of structure-based drug designs, growing academic and government investments in genomics and proteomics research, rising life sciences research funding, high biopharmaceutical R&D expenditure, and the emerging adoption of advanced technologies in North America. The presence of a large number of global players in this region is another key factor contributing to the large share of this market segment.
Break of primary participants was as mentioned below:
The key players operating in the genetic toxicology testing market include Thermo Fisher Scientific Inc. (US), Charles River Laboratories International, Inc. (US), Creative Bioarray (US), Laboratory Corp Of America Holdings (US), Jubilant Life Sciences Limited (India), Cyprotex PLC (UK), Merck KGaA (Germany), Shanghai Medicilon Inc. (China), Eurofins Scientific (Germany), Creative Biolabs (US), Toxikon Corporation (US), Environmental Bio-Detection Products Inc. (EBPI) (Canada), Gentronix Limited (UK), MB Research Laboratories (US), and Sotera Health LLC (US).
Research Coverage:
The report analyzes the genetic toxicology testing market and aims at estimating the market size and future growth potential of this market based on various segments such as product, application, and region. The report also includes a product portfolio matrix of various genetic toxicology testing products available in the market. The report also provides a competitive analysis of the key players in this market, along with their company profiles, product offerings, and key market strategies.
Reasons to Buy the Report
The report will enrich established firms as well as new entrants/smaller firms to gauge the pulse of the market, which in turn would help them, garner a more significant share of the market. Firms purchasing the report could use one or any combination of the below-mentioned strategies to strengthen their position in the market.
This report provides insights into the following pointers:
Based on product, the services segment holds the largest market share during the forecast period.
Based on product, the genetic toxicology testing market is segmented into reagents & consumables, assays, and services. The services segment accounted for the larger market share in 2019. The growing R&D activities in the pharmaceutical industry, growing government investments in the field of life sciences research, and the increasing research being undertaken with integrated omics studies, which is leading to increased outsourcing of services to contract research organizations (CROs), are factors attributing to the larger share of the segment.
Based on application, the cosmetics industry segment is expected to register the highest CAGR during the forecast period.
Based on application, the genetic toxicology testing market is segmented into the healthcare industry (pharmaceutical & biotechnology), food industry, cosmetic industry, and others (agriculture and chemical industries). The cosmetics industry segment is expected to witness the highest growth during the forecast period. The increasing use of cosmetics owing to the rising disposable incomes and their easy availability to the public has driven the industry to invest in the research of breakthrough products and develop safe products are set to drive market growth.
North America is expected to account for the largest share of the genetic toxicology testing market in 2019
In 2019, North America accounted for the largest share of the genetic toxicology testing market, followed by Europe, the Asia Pacific, Latin America, and the Middle East & Africa. The large share of this market segment can be attributed to the increasing development of structure-based drug designs, growing academic and government investments in genomics and proteomics research, rising life sciences research funding, high biopharmaceutical R&D expenditure, and the emerging adoption of advanced technologies in North America. The presence of a large number of global players in this region is another key factor contributing to the large share of this market segment.
Break of primary participants was as mentioned below:
- By Company Type – Tier 1–35%, Tier 2–45%, and Tier 3–20%
- By Designation – C-level–35%, Director-level–25%, Others–40%
- By Region – North America–45%, Europe–30%, Asia Pacific–20%, Latin America- 3%, Middle East and Africa–2%
The key players operating in the genetic toxicology testing market include Thermo Fisher Scientific Inc. (US), Charles River Laboratories International, Inc. (US), Creative Bioarray (US), Laboratory Corp Of America Holdings (US), Jubilant Life Sciences Limited (India), Cyprotex PLC (UK), Merck KGaA (Germany), Shanghai Medicilon Inc. (China), Eurofins Scientific (Germany), Creative Biolabs (US), Toxikon Corporation (US), Environmental Bio-Detection Products Inc. (EBPI) (Canada), Gentronix Limited (UK), MB Research Laboratories (US), and Sotera Health LLC (US).
Research Coverage:
The report analyzes the genetic toxicology testing market and aims at estimating the market size and future growth potential of this market based on various segments such as product, application, and region. The report also includes a product portfolio matrix of various genetic toxicology testing products available in the market. The report also provides a competitive analysis of the key players in this market, along with their company profiles, product offerings, and key market strategies.
Reasons to Buy the Report
The report will enrich established firms as well as new entrants/smaller firms to gauge the pulse of the market, which in turn would help them, garner a more significant share of the market. Firms purchasing the report could use one or any combination of the below-mentioned strategies to strengthen their position in the market.
This report provides insights into the following pointers:
- Market Penetration: Comprehensive information on product portfolios offered by the top players in the global genetic toxicology testing market. The report analyzes this market by product, and application
- Product Enhancement/Innovation: Detailed insights on upcoming trends and product launches in the global genetic toxicology testing market
- Market Development: Comprehensive information on the lucrative emerging markets by product, and application
- Market Diversification: Exhaustive information about new products or product enhancements, growing geographies, recent developments, and investments in the global genetic toxicology testing market
- Competitive Assessment: In-depth assessment of market shares, growth strategies, product offerings, competitive leadership mapping, and capabilities of leading players in the global genetic toxicology testing market.
1 INTRODUCTION
1.1 OBJECTIVES OF THE STUDY
1.2 MARKET DEFINITION & SCOPE
1.2.1 INCLUSIONS AND EXCLUSIONS
1.2.2 MARKETS COVERED
FIGURE 1 GENETIC TOXICOLOGY TESTING MARKET
1.2.3 YEARS CONSIDERED FOR STUDY
1.3 CURRENCY
1.4 STAKEHOLDERS
1.5 LIMITATIONS
2 RESEARCH METHODOLOGY
2.1 RESEARCH APPROACH
FIGURE 2 RESEARCH DESIGN
2.1.1 SECONDARY RESEARCH
2.1.2 KEY DATA FROM SECONDARY SOURCES
2.2 PRIMARY RESEARCH
2.2.1 PRIMARY SOURCES
2.2.1.1 Breakdown of primaries
FIGURE 3 BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION, AND REGION
2.3 MARKET SIZE ESTIMATION
FIGURE 4 MARKET SIZE ESTIMATION: REVENUE SHARE ANALYSIS
FIGURE 5 MARKET ANALYSIS APPROACH
FIGURE 6 TOP-DOWN APPROACH
2.4 DATA TRIANGULATION APPROACH
FIGURE 7 DATA TRIANGULATION METHODOLOGY
2.5 MARKET SHARE ESTIMATION
2.6 ASSUMPTIONS FOR STUDY
3 EXECUTIVE SUMMARY
FIGURE 8 GENETIC TOXICOLOGY TESTING MARKET, BY PRODUCT, 2020 VS. 2025 (USD MILLION)
FIGURE 9 GENETIC TOXICOLOGY TESTING MARKET, BY APPLICATION, 2020 VS. 2025 (USD MILLION)
FIGURE 10 GEOGRAPHIC ANALYSIS: GENETIC TOXICOLOGY TESTING MARKET
4 PREMIUM INSIGHTS
4.1 GENETIC TOXICOLOGY TESTING MARKET OVERVIEW
FIGURE 11 INCREASING RESEARCH BEING CONDUCTED USING GENE-BASED TECHNOLOGIES TO DRIVE MARKET GROWTH
4.2 EUROPE: GENETIC TOXICOLOGY TESTING MARKET, BY PRODUCT
FIGURE 12 SERVICES SEGMENT ACCOUNTED FOR LARGEST SHARE OF EUROPEAN GENETIC TOXICOLOGY TESTING MARKET IN 2019
4.3 GENETIC TOXICOLOGY TESTING MARKET: GEOGRAPHIC GROWTH OPPORTUNITIES
FIGURE 13 MARKET IN ASIA PACIFIC TO WITNESS HIGHEST GROWTH DURING FORECAST PERIOD
4.4 GENETIC TOXICOLOGY TESTING MARKET, BY REGION (2018–2025)
FIGURE 14 NORTH AMERICA TO CONTINUE DOMINATING GENETIC TOXICOLOGY TESTING MARKET UNTIL 2025
5 MARKET OVERVIEW
5.1 INTRODUCTION
5.2 MARKET DYNAMICS
TABLE 1 GENETIC TOXICOLOGY SERVICES MARKET: IMPACT ANALYSIS
5.2.1 MARKET DRIVERS
5.2.1.1 Increased number of pharmaceutical R&D activities
FIGURE 15 R&D INVESTMENTS, BY COUNTRY, 2017 VS. 2018 (USD BILLION)
5.2.1.2 Opposition to animal testing of drugs and cosmetics
5.2.1.3 R&D activities for early toxicity detection in drugs
5.2.2 MARKET RESTRAINTS
5.2.2.1 Lack of validated in vitro models to study complex endpoints
5.2.2.2 Reluctance of countries toward replacement of in vivo methods with alternative testing
5.2.2.3 Failure of in vitro methods to achieve intricacies similar to in vivo methods
5.2.3 MARKET OPPORTUNITIES
5.2.3.1 Increased focus on drug discovery and personalized medicines using in vitro methods
5.2.3.2 Risen global demand for humanized animal models
5.2.4 MARKET CHALLENGES
5.2.4.1 Regulations and laws to ensure ethical use of animals in research activities
TABLE 2 REGULATORY AUTHORITIES OVERSEEING USE OF ANIMAL MODELS IN RESEARCH ACTIVITIES
5.2.4.2 Dearth of skilled professionals
5.3 INDUSTRY TRENDS
5.3.1 INCREASING FOCUS ON PREDICTIVE TOXICOLOGY
5.4 PARENT MARKET (IN VITRO TOXICOLOGY TESTING): SUPPLY CHAIN ANALYSIS
FIGURE 16 SUPPLY CHAIN ANALYSIS: IN VITRO TOXICOLOGY TESTING MARKET
5.5 COVID- 19 HEALTH ASSESSMENT
FIGURE 17 GLOBAL PROPAGATION OF COVID-19
FIGURE 18 COVID-19 PROPAGATION: SELECT COUNTRIES
5.6 COVID-19 IMPACT ON GENETIC TOXICOLOGY SERVICES MARKET
6 GENETIC TOXICOLOGY TESTING MARKET, BY PRODUCT
6.1 INTRODUCTION
FIGURE 19 SERVICES SEGMENT TO LEAD GENETIC TOXICOLOGY TESTING MARKET DURING FORECAST PERIOD
TABLE 3 GENETIC TOXICOLOGY TESTING MARKET, BY PRODUCT, 2018–2025 (USD MILLION)
6.2 SERVICES
6.2.1 INCREASED TREND OF OUTSOURCING TOXICITY TESTING SERVICES BY KEY INDUSTRIES SUCH AS PHARMACEUTICALS AND CHEMICALS TO FOSTER MARKET GROWTH
TABLE 4 GENETIC TOXICOLOGY SERVICES MARKET, BY COUNTRY, 2018–2025 (USD MILLION)
6.3 REAGENTS AND CONSUMABLES
6.3.1 REPETITIVE USE OF CONSUMABLES IN TESTING ACTIVITIES SUPPORTS MARKET GROWTH
TABLE 5 GENETIC TOXICOLOGY REAGENTS AND CONSUMABLES MARKET, BY COUNTRY, 2018–2025 (USD MILLION)
6.4 ASSAYS
6.4.1 INCREASED NEED FOR ACCURATE ANALYSIS DRIVES ADOPTION OF DIFFERENT TYPES OF ASSAYS
TABLE 6 GENETIC TOXICOLOGY ASSAYS MARKET, BY COUNTRY, 2018–2025 (USD MILLION)
7 GENETIC TOXICOLOGY TESTING MARKET, BY APPLICATION
7.1 INTRODUCTION
7.2 COVID-19 IMPACT, BY APPLICATION
FIGURE 20 HEALTHCARE INDUSTRY TO ACCOUNT FOR LARGEST MARKET SIZE DURING FORECAST PERIOD
TABLE 7 GENETIC TOXICOLOGY TESTING MARKET, BY APPLICATION, 2018–2025 (USD MILLION)
7.3 HEALTHCARE INDUSTRY
7.3.1 INCREASING R&D INVESTMENTS IN ONCOLOGY FIELD TO BOOST DEMAND FOR GENOTOXICOLOGY TESTING
TABLE 8 GENETIC TOXICOLOGY TESTING MARKET FOR HEALTHCARE INDUSTRY, BY COUNTRY, 2018–2025 (USD MILLION)
7.4 FOOD INDUSTRY
7.4.1 GROWING FOCUS ON FOOD SAFETY TO PROPEL MARKET GROWTH
TABLE 9 GENETIC TOXICOLOGY TESTING MARKET FOR FOOD INDUSTRY, BY COUNTRY, 2018–2025 (USD MILLION)
7.5 COSMETICS INDUSTRY
7.5.1 RISING ADOPTION OF IN VITRO GENOTOXICOLOGY ASSAYS DUE TO BAN ON ANIMAL TESTING FOR COSMETIC PRODUCTS AND INGREDIENTS TO SPUR MARKET GROWTH
TABLE 10 GENETIC TOXICOLOGY TESTING MARKET FOR COSMETICS INDUSTRY, BY COUNTRY, 2018–2025 (USD MILLION)
7.6 OTHER INDUSTRIES
TABLE 11 GENETIC TOXICOLOGY TESTING MARKET FOR OTHER INDUSTRIES, BY COUNTRY, 2018–2025 (USD MILLION)
8 GENETIC TOXICOLOGY TESTING MARKET, BY REGION
8.1 INTRODUCTION
8.2 COVID-19 IMPACT, BY REGION
TABLE 12 GENETIC TOXICOLOGY TESTING MARKET, BY REGION, 2018–2025 (USD MILLION)
8.3 NORTH AMERICA
FIGURE 21 TOTAL NUMBER OF CLINICAL TRIALS: GLOBAL VS. NORTH AMERICA, 2017
FIGURE 22 NORTH AMERICA: GENETIC TOXICOLOGY TESTING MARKET SNAPSHOT
TABLE 13 NORTH AMERICA: GENETIC TOXICOLOGY TESTING MARKET, BY COUNTRY, 2018–2025 (USD MILLION)
TABLE 14 NORTH AMERICA: GENETIC TOXICOLOGY TESTING MARKET, BY PRODUCT, 2018–2025 (USD MILLION)
TABLE 15 NORTH AMERICA: GENETIC TOXICOLOGY TESTING MARKET, BY APPLICATION, 2018–2025 (USD MILLION)
8.3.1 US
8.3.1.1 US dominates North American market
TABLE 16 US: NIH BUDGET FOR VARIOUS DISCIPLINES, FY 2019 VS. FY 2020
(USD BILLION)
TABLE 17 US: GENETIC TOXICOLOGY TESTING MARKET, BY PRODUCT, 2018–2025 (USD MILLION)
TABLE 18 US: GENETIC TOXICOLOGY TESTING MARKET, BY APPLICATION, 2018–2025 (USD MILLION)
8.3.2 CANADA
8.3.2.1 Increasing funding and improved infrastructure for gene-based research supporting market growth
TABLE 19 CANADA: GENETIC TOXICOLOGY TESTING MARKET, BY PRODUCT, 2018–2025 (USD MILLION)
TABLE 20 CANADA: GENETIC TOXICOLOGY TESTING MARKET, BY APPLICATION, 2018–2025 (USD MILLION)
8.4 EUROPE
FIGURE 23 EUROPE: GENETIC TOXICOLOGY TESTING MARKET SNAPSHOT
TABLE 21 EUROPE: GENETIC TOXICOLOGY TESTING MARKET, BY COUNTRY, 2018–2025 (USD MILLION)
TABLE 22 EUROPE: GENETIC TOXICOLOGY TESTING MARKET, BY PRODUCT, 2018–2025 (USD MILLION)
TABLE 23 EUROPE: GENETIC TOXICOLOGY TESTING MARKET, BY APPLICATION, 2018–2025 (USD MILLION)
8.4.1 GERMANY
8.4.1.1 Growing R&D activities in genomics to propel market growth
TABLE 24 GERMANY: GENETIC TOXICOLOGY TESTING MARKET, BY PRODUCT, 2018–2025 (USD MILLION)
TABLE 25 GERMANY: GENETIC TOXICOLOGY TESTING MARKET, BY APPLICATION, 2018–2025 (USD MILLION)
8.4.2 FRANCE
8.4.2.1 Increasing government support for gene-based research to support market growth
TABLE 26 FRANCE: GENETIC TOXICOLOGY TESTING MARKET, BY PRODUCT, 2018–2025 (USD MILLION)
TABLE 27 FRANCE: GENETIC TOXICOLOGY TESTING MARKET, BY APPLICATION, 2018–2025 (USD MILLION)
8.4.3 UK
8.4.3.1 Rising public and private funding for research to drive market growth
TABLE 28 UK: GENETIC TOXICOLOGY TESTING MARKET, BY PRODUCT, 2018–2025 (USD MILLION)
TABLE 29 UK: GENETIC TOXICOLOGY TESTING MARKET, BY APPLICATION, 2018–2025 (USD MILLION)
8.4.4 REST OF EUROPE
TABLE 30 ROE: GENETIC TOXICOLOGY TESTING MARKET, BY PRODUCT, 2018–2025 (USD MILLION)
TABLE 31 ROE: GENETIC TOXICOLOGY TESTING MARKET, BY APPLICATION, 2018–2025 (USD MILLION)
8.5 ASIA PACIFIC
8.5.1 INCREASING RESEARCH FUNDING AND GROWING AWARENESS ABOUT PERSONALIZED THERAPEUTICS TO SUPPORT MARKET GROWTH
TABLE 32 ASIA PACIFIC: GENETIC TOXICOLOGY TESTING MARKET, BY PRODUCT, 2018–2025 (USD MILLION)
TABLE 33 ASIA PACIFIC: GENETIC TOXICOLOGY TESTING MARKET, BY APPLICATION, 2018–2025 (USD MILLION)
8.6 LATIN AMERICA
8.6.1 GROWTH IN PHARMACEUTICAL INDUSTRY IN MEXICO TO SUPPORT MARKET GROWTH
TABLE 34 LATIN AMERICA: GENETIC TOXICOLOGY TESTING MARKET, BY PRODUCT, 2018–2025 (USD MILLION)
TABLE 35 LATIN AMERICA: GENETIC TOXICOLOGY TESTING MARKET, BY APPLICATION, 2018–2025 (USD MILLION)
8.7 MIDDLE EAST & AFRICA
8.7.1 IMPROVING FOCUS ON PRECISION MEDICINE AND DISEASE GENETICS DRIVING MARKET GROWTH
TABLE 36 MIDDLE EAST & AFRICA: GENETIC TOXICOLOGY TESTING MARKET, BY PRODUCT, 2018–2025 (USD MILLION)
TABLE 37 MIDDLE EAST & AFRICA: GENETIC TOXICOLOGY TESTING MARKET, BY APPLICATION, 2018–2025 (USD MILLION)
9 COMPETITIVE LANDSCAPE
9.1 OVERVIEW
FIGURE 24 PRODUCT LAUNCHES—KEY GROWTH STRATEGY ADOPTED BY MARKET PLAYERS FROM 2017 TO NOVEMBER 2020
9.2 MARKET SHARE ANALYSIS
FIGURE 25 GENETIC TOXICOLOGY SERVICES MARKET SHARE, BY KEY PLAYER, 2019
9.3 COMPANY EVALUATION MATRIX
9.3.1 STAR
9.3.2 EMERGING LEADER
9.3.3 PERVASIVE
9.3.4 EMERGING COMPANIES
FIGURE 26 GENETIC TOXICOLOGY SERVICES MARKET: COMPETITIVE LEADERSHIP MAPPING (2019)
9.4 COMPETITIVE SITUATION AND TRENDS
9.4.1 EXPANSIONS
TABLE 38 EXPANSIONS, 2017–2020
9.4.2 ACQUISITIONS
TABLE 39 ACQUISITIONS, 2017–2020
9.4.3 OTHER STRATEGIES
TABLE 40 OTHER STRATEGIES, 2017–2020
10 COMPANY PROFILES
10.1 THERMO FISHER SCIENTIFIC INC.
FIGURE 27 THERMO FISHER SCIENTIFIC INC.: COMPANY SNAPSHOT (2019)
10.2 CHARLES RIVER LABORATORIES INTERNATIONAL, INC.
FIGURE 28 CHARLES RIVER LABORATORIES INTERNATIONAL, INC.: COMPANY SNAPSHOT (2019)
10.3 CREATIVE BIOARRAY
10.4 CYPROTEX PLC
FIGURE 29 EVOTEC AG: COMPANY SNAPSHOT (2019)
10.5 LABORATORY CORP OF AMERICA HOLDINGS
FIGURE 30 LABORATORY CORP OF AMERICA HOLDINGS: COMPANY SNAPSHOT (2019)
10.6 JUBILANT LIFE SCIENCES LIMITED
FIGURE 31 JUBILANT LIFE SCIENCES LIMITED: COMPANY SNAPSHOT (2020)
10.7 MERCK KGAA (MILLIPORE SIGMA )
FIGURE 32 MERCK KGAA: COMPANY SNAPSHOT (2019)
10.8 SHANGHAI MEDICILON INC.
10.9 EUROFINS SCIENTIFIC
FIGURE 33 EUROFINS SCIENTIFIC: COMPANY SNAPSHOT (2019)
10.10 CREATIVE BIOLABS
10.11 TOXIKON CORPORATION
10.12 ENVIRONMENTAL BIO-DETECTION PRODUCTS INC. (EBPI)
10.13 GENTRONIX LIMITED
10.14 MB RESEARCH LABORATORIES
10.15 SOTERA HEALTH LLC
11 APPENDIX
11.1 INSIGHTS OF INDUSTRY EXPERTS
11.2 DISCUSSION GUIDE
11.3 KNOWLEDGE STORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL
11.4 AVAILABLE CUSTOMIZATIONS
11.5 RELATED REPORTS
11.6 AUTHOR DETAILS
LIST OF TABLES
TABLE 1 GENETIC TOXICOLOGY SERVICES MARKET: IMPACT ANALYSIS
TABLE 2 REGULATORY AUTHORITIES OVERSEEING USE OF ANIMAL MODELS IN RESEARCH ACTIVITIES
TABLE 3 GENETIC TOXICOLOGY TESTING MARKET, BY PRODUCT, 2018–2025 (USD MILLION)
TABLE 4 GENETIC TOXICOLOGY SERVICES MARKET, BY COUNTRY, 2018–2025 (USD MILLION)
TABLE 5 GENETIC TOXICOLOGY REAGENTS AND CONSUMABLES MARKET, BY COUNTRY, 2018–2025 (USD MILLION)
TABLE 6 GENETIC TOXICOLOGY ASSAYS MARKET, BY COUNTRY, 2018–2025 (USD MILLION)
TABLE 7 GENETIC TOXICOLOGY TESTING MARKET, BY APPLICATION, 2018–2025 (USD MILLION)
TABLE 8 GENETIC TOXICOLOGY TESTING MARKET FOR HEALTHCARE INDUSTRY, BY COUNTRY, 2018–2025 (USD MILLION)
TABLE 9 GENETIC TOXICOLOGY TESTING MARKET FOR FOOD INDUSTRY, BY COUNTRY, 2018–2025 (USD MILLION)
TABLE 10 GENETIC TOXICOLOGY TESTING MARKET FOR COSMETICS INDUSTRY, BY COUNTRY, 2018–2025 (USD MILLION)
TABLE 11 GENETIC TOXICOLOGY TESTING MARKET FOR OTHER INDUSTRIES, BY COUNTRY, 2018–2025 (USD MILLION)
TABLE 12 GENETIC TOXICOLOGY TESTING MARKET, BY REGION, 2018–2025 (USD MILLION)
TABLE 13 NORTH AMERICA: GENETIC TOXICOLOGY TESTING MARKET, BY COUNTRY, 2018–2025 (USD MILLION)
TABLE 14 NORTH AMERICA: GENETIC TOXICOLOGY TESTING MARKET, BY PRODUCT, 2018–2025 (USD MILLION)
TABLE 15 NORTH AMERICA: GENETIC TOXICOLOGY TESTING MARKET, BY APPLICATION, 2018–2025 (USD MILLION)
TABLE 16 US: NIH BUDGET FOR VARIOUS DISCIPLINES, FY 2019 VS. FY 2020 (USD BILLION)
TABLE 17 US: GENETIC TOXICOLOGY TESTING MARKET, BY PRODUCT, 2018–2025 (USD MILLION)
TABLE 18 US: GENETIC TOXICOLOGY TESTING MARKET, BY APPLICATION, 2018–2025 (USD MILLION)
TABLE 19 CANADA: GENETIC TOXICOLOGY TESTING MARKET, BY PRODUCT, 2018–2025 (USD MILLION)
TABLE 20 CANADA: GENETIC TOXICOLOGY TESTING MARKET, BY APPLICATION, 2018–2025 (USD MILLION)
TABLE 21 EUROPE: GENETIC TOXICOLOGY TESTING MARKET, BY COUNTRY, 2018–2025 (USD MILLION)
TABLE 22 EUROPE: GENETIC TOXICOLOGY TESTING MARKET, BY PRODUCT, 2018–2025 (USD MILLION)
TABLE 23 EUROPE: GENETIC TOXICOLOGY TESTING MARKET, BY APPLICATION, 2018–2025 (USD MILLION)
TABLE 24 GERMANY: GENETIC TOXICOLOGY TESTING MARKET, BY PRODUCT, 2018–2025 (USD MILLION)
TABLE 25 GERMANY: GENETIC TOXICOLOGY TESTING MARKET, BY APPLICATION, 2018–2025 (USD MILLION)
TABLE 26 FRANCE: GENETIC TOXICOLOGY TESTING MARKET, BY PRODUCT, 2018–2025 (USD MILLION)
TABLE 27 FRANCE: GENETIC TOXICOLOGY TESTING MARKET, BY APPLICATION, 2018–2025 (USD MILLION)
TABLE 28 UK: GENETIC TOXICOLOGY TESTING MARKET, BY PRODUCT, 2018–2025 (USD MILLION)
TABLE 29 UK: GENETIC TOXICOLOGY TESTING MARKET, BY APPLICATION, 2018–2025 (USD MILLION)
TABLE 30 ROE: GENETIC TOXICOLOGY TESTING MARKET, BY PRODUCT, 2018–2025 (USD MILLION)
TABLE 31 ROE: GENETIC TOXICOLOGY TESTING MARKET, BY APPLICATION, 2018–2025 (USD MILLION)
TABLE 32 ASIA PACIFIC: GENETIC TOXICOLOGY TESTING MARKET, BY PRODUCT, 2018–2025 (USD MILLION)
TABLE 33 ASIA PACIFIC: GENETIC TOXICOLOGY TESTING MARKET, BY APPLICATION, 2018–2025 (USD MILLION)
TABLE 34 LATIN AMERICA: GENETIC TOXICOLOGY TESTING MARKET, BY PRODUCT, 2018–2025 (USD MILLION)
TABLE 35 LATIN AMERICA: GENETIC TOXICOLOGY TESTING MARKET, BY APPLICATION, 2018–2025 (USD MILLION)
TABLE 36 MIDDLE EAST & AFRICA: GENETIC TOXICOLOGY TESTING MARKET, BY PRODUCT, 2018–2025 (USD MILLION)
TABLE 37 MIDDLE EAST & AFRICA: GENETIC TOXICOLOGY TESTING MARKET, BY APPLICATION, 2018–2025 (USD MILLION)
TABLE 38 EXPANSIONS, 2017–2020
TABLE 39 ACQUISITIONS, 2017–2020
TABLE 40 OTHER STRATEGIES, 2017–2020
LIST OF FIGURES
FIGURE 1 GENETIC TOXICOLOGY TESTING MARKET
FIGURE 2 RESEARCH DESIGN
FIGURE 3 BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION, AND REGION
FIGURE 4 MARKET SIZE ESTIMATION: REVENUE SHARE ANALYSIS
FIGURE 5 MARKET ANALYSIS APPROACH
FIGURE 6 TOP-DOWN APPROACH
FIGURE 7 DATA TRIANGULATION METHODOLOGY
FIGURE 8 GENETIC TOXICOLOGY TESTING MARKET, BY PRODUCT, 2020 VS. 2025 (USD MILLION)
FIGURE 9 GENETIC TOXICOLOGY TESTING MARKET, BY APPLICATION, 2020 VS. 2025 (USD MILLION)
FIGURE 10 GEOGRAPHIC ANALYSIS: GENETIC TOXICOLOGY TESTING MARKET
FIGURE 11 INCREASING RESEARCH BEING CONDUCTED USING GENE-BASED TECHNOLOGIES TO DRIVE MARKET GROWTH
FIGURE 12 SERVICES SEGMENT ACCOUNTED FOR LARGEST SHARE OF EUROPEAN GENETIC TOXICOLOGY TESTING MARKET IN 2019
FIGURE 13 MARKET IN ASIA PACIFIC TO WITNESS HIGHEST GROWTH DURING
FORECAST PERIOD
FIGURE 14 NORTH AMERICA TO CONTINUE DOMINATING GENETIC TOXICOLOGY TESTING MARKET UNTIL 2025
FIGURE 15 R&D INVESTMENTS, BY COUNTRY, 2017 VS. 2018 (USD BILLION)
FIGURE 16 SUPPLY CHAIN ANALYSIS: IN VITRO TOXICOLOGY TESTING MARKET
FIGURE 17 GLOBAL PROPAGATION OF COVID-19
FIGURE 18 COVID-19 PROPAGATION: SELECT COUNTRIES
FIGURE 19 SERVICES SEGMENT TO LEAD GENETIC TOXICOLOGY TESTING MARKET DURING FORECAST PERIOD
FIGURE 20 HEALTHCARE INDUSTRY TO ACCOUNT FOR LARGEST MARKET SIZE DURING FORECAST PERIOD
FIGURE 21 TOTAL NUMBER OF CLINICAL TRIALS: GLOBAL VS. NORTH AMERICA, 2017
FIGURE 22 NORTH AMERICA: GENETIC TOXICOLOGY TESTING MARKET SNAPSHOT
FIGURE 23 EUROPE: GENETIC TOXICOLOGY TESTING MARKET SNAPSHOT
FIGURE 24 PRODUCT LAUNCHES—KEY GROWTH STRATEGY ADOPTED BY MARKET PLAYERS FROM 2017 TO NOVEMBER 2020
FIGURE 25 GENETIC TOXICOLOGY SERVICES MARKET SHARE, BY KEY PLAYER, 2019
FIGURE 26 GENETIC TOXICOLOGY SERVICES MARKET: COMPETITIVE LEADERSHIP
MAPPING (2019)
FIGURE 27 THERMO FISHER SCIENTIFIC INC.: COMPANY SNAPSHOT (2019)
FIGURE 28 CHARLES RIVER LABORATORIES INTERNATIONAL, INC.: COMPANY
SNAPSHOT (2019)
FIGURE 29 EVOTEC AG: COMPANY SNAPSHOT (2019)
FIGURE 30 LABORATORY CORP OF AMERICA HOLDINGS: COMPANY SNAPSHOT (2019)
FIGURE 31 JUBILANT LIFE SCIENCES LIMITED: COMPANY SNAPSHOT (2020)
FIGURE 32 MERCK KGAA: COMPANY SNAPSHOT (2019)
FIGURE 33 EUROFINS SCIENTIFIC: COMPANY SNAPSHOT (2019)
1.1 OBJECTIVES OF THE STUDY
1.2 MARKET DEFINITION & SCOPE
1.2.1 INCLUSIONS AND EXCLUSIONS
1.2.2 MARKETS COVERED
FIGURE 1 GENETIC TOXICOLOGY TESTING MARKET
1.2.3 YEARS CONSIDERED FOR STUDY
1.3 CURRENCY
1.4 STAKEHOLDERS
1.5 LIMITATIONS
2 RESEARCH METHODOLOGY
2.1 RESEARCH APPROACH
FIGURE 2 RESEARCH DESIGN
2.1.1 SECONDARY RESEARCH
2.1.2 KEY DATA FROM SECONDARY SOURCES
2.2 PRIMARY RESEARCH
2.2.1 PRIMARY SOURCES
2.2.1.1 Breakdown of primaries
FIGURE 3 BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION, AND REGION
2.3 MARKET SIZE ESTIMATION
FIGURE 4 MARKET SIZE ESTIMATION: REVENUE SHARE ANALYSIS
FIGURE 5 MARKET ANALYSIS APPROACH
FIGURE 6 TOP-DOWN APPROACH
2.4 DATA TRIANGULATION APPROACH
FIGURE 7 DATA TRIANGULATION METHODOLOGY
2.5 MARKET SHARE ESTIMATION
2.6 ASSUMPTIONS FOR STUDY
3 EXECUTIVE SUMMARY
FIGURE 8 GENETIC TOXICOLOGY TESTING MARKET, BY PRODUCT, 2020 VS. 2025 (USD MILLION)
FIGURE 9 GENETIC TOXICOLOGY TESTING MARKET, BY APPLICATION, 2020 VS. 2025 (USD MILLION)
FIGURE 10 GEOGRAPHIC ANALYSIS: GENETIC TOXICOLOGY TESTING MARKET
4 PREMIUM INSIGHTS
4.1 GENETIC TOXICOLOGY TESTING MARKET OVERVIEW
FIGURE 11 INCREASING RESEARCH BEING CONDUCTED USING GENE-BASED TECHNOLOGIES TO DRIVE MARKET GROWTH
4.2 EUROPE: GENETIC TOXICOLOGY TESTING MARKET, BY PRODUCT
FIGURE 12 SERVICES SEGMENT ACCOUNTED FOR LARGEST SHARE OF EUROPEAN GENETIC TOXICOLOGY TESTING MARKET IN 2019
4.3 GENETIC TOXICOLOGY TESTING MARKET: GEOGRAPHIC GROWTH OPPORTUNITIES
FIGURE 13 MARKET IN ASIA PACIFIC TO WITNESS HIGHEST GROWTH DURING FORECAST PERIOD
4.4 GENETIC TOXICOLOGY TESTING MARKET, BY REGION (2018–2025)
FIGURE 14 NORTH AMERICA TO CONTINUE DOMINATING GENETIC TOXICOLOGY TESTING MARKET UNTIL 2025
5 MARKET OVERVIEW
5.1 INTRODUCTION
5.2 MARKET DYNAMICS
TABLE 1 GENETIC TOXICOLOGY SERVICES MARKET: IMPACT ANALYSIS
5.2.1 MARKET DRIVERS
5.2.1.1 Increased number of pharmaceutical R&D activities
FIGURE 15 R&D INVESTMENTS, BY COUNTRY, 2017 VS. 2018 (USD BILLION)
5.2.1.2 Opposition to animal testing of drugs and cosmetics
5.2.1.3 R&D activities for early toxicity detection in drugs
5.2.2 MARKET RESTRAINTS
5.2.2.1 Lack of validated in vitro models to study complex endpoints
5.2.2.2 Reluctance of countries toward replacement of in vivo methods with alternative testing
5.2.2.3 Failure of in vitro methods to achieve intricacies similar to in vivo methods
5.2.3 MARKET OPPORTUNITIES
5.2.3.1 Increased focus on drug discovery and personalized medicines using in vitro methods
5.2.3.2 Risen global demand for humanized animal models
5.2.4 MARKET CHALLENGES
5.2.4.1 Regulations and laws to ensure ethical use of animals in research activities
TABLE 2 REGULATORY AUTHORITIES OVERSEEING USE OF ANIMAL MODELS IN RESEARCH ACTIVITIES
5.2.4.2 Dearth of skilled professionals
5.3 INDUSTRY TRENDS
5.3.1 INCREASING FOCUS ON PREDICTIVE TOXICOLOGY
5.4 PARENT MARKET (IN VITRO TOXICOLOGY TESTING): SUPPLY CHAIN ANALYSIS
FIGURE 16 SUPPLY CHAIN ANALYSIS: IN VITRO TOXICOLOGY TESTING MARKET
5.5 COVID- 19 HEALTH ASSESSMENT
FIGURE 17 GLOBAL PROPAGATION OF COVID-19
FIGURE 18 COVID-19 PROPAGATION: SELECT COUNTRIES
5.6 COVID-19 IMPACT ON GENETIC TOXICOLOGY SERVICES MARKET
6 GENETIC TOXICOLOGY TESTING MARKET, BY PRODUCT
6.1 INTRODUCTION
FIGURE 19 SERVICES SEGMENT TO LEAD GENETIC TOXICOLOGY TESTING MARKET DURING FORECAST PERIOD
TABLE 3 GENETIC TOXICOLOGY TESTING MARKET, BY PRODUCT, 2018–2025 (USD MILLION)
6.2 SERVICES
6.2.1 INCREASED TREND OF OUTSOURCING TOXICITY TESTING SERVICES BY KEY INDUSTRIES SUCH AS PHARMACEUTICALS AND CHEMICALS TO FOSTER MARKET GROWTH
TABLE 4 GENETIC TOXICOLOGY SERVICES MARKET, BY COUNTRY, 2018–2025 (USD MILLION)
6.3 REAGENTS AND CONSUMABLES
6.3.1 REPETITIVE USE OF CONSUMABLES IN TESTING ACTIVITIES SUPPORTS MARKET GROWTH
TABLE 5 GENETIC TOXICOLOGY REAGENTS AND CONSUMABLES MARKET, BY COUNTRY, 2018–2025 (USD MILLION)
6.4 ASSAYS
6.4.1 INCREASED NEED FOR ACCURATE ANALYSIS DRIVES ADOPTION OF DIFFERENT TYPES OF ASSAYS
TABLE 6 GENETIC TOXICOLOGY ASSAYS MARKET, BY COUNTRY, 2018–2025 (USD MILLION)
7 GENETIC TOXICOLOGY TESTING MARKET, BY APPLICATION
7.1 INTRODUCTION
7.2 COVID-19 IMPACT, BY APPLICATION
FIGURE 20 HEALTHCARE INDUSTRY TO ACCOUNT FOR LARGEST MARKET SIZE DURING FORECAST PERIOD
TABLE 7 GENETIC TOXICOLOGY TESTING MARKET, BY APPLICATION, 2018–2025 (USD MILLION)
7.3 HEALTHCARE INDUSTRY
7.3.1 INCREASING R&D INVESTMENTS IN ONCOLOGY FIELD TO BOOST DEMAND FOR GENOTOXICOLOGY TESTING
TABLE 8 GENETIC TOXICOLOGY TESTING MARKET FOR HEALTHCARE INDUSTRY, BY COUNTRY, 2018–2025 (USD MILLION)
7.4 FOOD INDUSTRY
7.4.1 GROWING FOCUS ON FOOD SAFETY TO PROPEL MARKET GROWTH
TABLE 9 GENETIC TOXICOLOGY TESTING MARKET FOR FOOD INDUSTRY, BY COUNTRY, 2018–2025 (USD MILLION)
7.5 COSMETICS INDUSTRY
7.5.1 RISING ADOPTION OF IN VITRO GENOTOXICOLOGY ASSAYS DUE TO BAN ON ANIMAL TESTING FOR COSMETIC PRODUCTS AND INGREDIENTS TO SPUR MARKET GROWTH
TABLE 10 GENETIC TOXICOLOGY TESTING MARKET FOR COSMETICS INDUSTRY, BY COUNTRY, 2018–2025 (USD MILLION)
7.6 OTHER INDUSTRIES
TABLE 11 GENETIC TOXICOLOGY TESTING MARKET FOR OTHER INDUSTRIES, BY COUNTRY, 2018–2025 (USD MILLION)
8 GENETIC TOXICOLOGY TESTING MARKET, BY REGION
8.1 INTRODUCTION
8.2 COVID-19 IMPACT, BY REGION
TABLE 12 GENETIC TOXICOLOGY TESTING MARKET, BY REGION, 2018–2025 (USD MILLION)
8.3 NORTH AMERICA
FIGURE 21 TOTAL NUMBER OF CLINICAL TRIALS: GLOBAL VS. NORTH AMERICA, 2017
FIGURE 22 NORTH AMERICA: GENETIC TOXICOLOGY TESTING MARKET SNAPSHOT
TABLE 13 NORTH AMERICA: GENETIC TOXICOLOGY TESTING MARKET, BY COUNTRY, 2018–2025 (USD MILLION)
TABLE 14 NORTH AMERICA: GENETIC TOXICOLOGY TESTING MARKET, BY PRODUCT, 2018–2025 (USD MILLION)
TABLE 15 NORTH AMERICA: GENETIC TOXICOLOGY TESTING MARKET, BY APPLICATION, 2018–2025 (USD MILLION)
8.3.1 US
8.3.1.1 US dominates North American market
TABLE 16 US: NIH BUDGET FOR VARIOUS DISCIPLINES, FY 2019 VS. FY 2020
(USD BILLION)
TABLE 17 US: GENETIC TOXICOLOGY TESTING MARKET, BY PRODUCT, 2018–2025 (USD MILLION)
TABLE 18 US: GENETIC TOXICOLOGY TESTING MARKET, BY APPLICATION, 2018–2025 (USD MILLION)
8.3.2 CANADA
8.3.2.1 Increasing funding and improved infrastructure for gene-based research supporting market growth
TABLE 19 CANADA: GENETIC TOXICOLOGY TESTING MARKET, BY PRODUCT, 2018–2025 (USD MILLION)
TABLE 20 CANADA: GENETIC TOXICOLOGY TESTING MARKET, BY APPLICATION, 2018–2025 (USD MILLION)
8.4 EUROPE
FIGURE 23 EUROPE: GENETIC TOXICOLOGY TESTING MARKET SNAPSHOT
TABLE 21 EUROPE: GENETIC TOXICOLOGY TESTING MARKET, BY COUNTRY, 2018–2025 (USD MILLION)
TABLE 22 EUROPE: GENETIC TOXICOLOGY TESTING MARKET, BY PRODUCT, 2018–2025 (USD MILLION)
TABLE 23 EUROPE: GENETIC TOXICOLOGY TESTING MARKET, BY APPLICATION, 2018–2025 (USD MILLION)
8.4.1 GERMANY
8.4.1.1 Growing R&D activities in genomics to propel market growth
TABLE 24 GERMANY: GENETIC TOXICOLOGY TESTING MARKET, BY PRODUCT, 2018–2025 (USD MILLION)
TABLE 25 GERMANY: GENETIC TOXICOLOGY TESTING MARKET, BY APPLICATION, 2018–2025 (USD MILLION)
8.4.2 FRANCE
8.4.2.1 Increasing government support for gene-based research to support market growth
TABLE 26 FRANCE: GENETIC TOXICOLOGY TESTING MARKET, BY PRODUCT, 2018–2025 (USD MILLION)
TABLE 27 FRANCE: GENETIC TOXICOLOGY TESTING MARKET, BY APPLICATION, 2018–2025 (USD MILLION)
8.4.3 UK
8.4.3.1 Rising public and private funding for research to drive market growth
TABLE 28 UK: GENETIC TOXICOLOGY TESTING MARKET, BY PRODUCT, 2018–2025 (USD MILLION)
TABLE 29 UK: GENETIC TOXICOLOGY TESTING MARKET, BY APPLICATION, 2018–2025 (USD MILLION)
8.4.4 REST OF EUROPE
TABLE 30 ROE: GENETIC TOXICOLOGY TESTING MARKET, BY PRODUCT, 2018–2025 (USD MILLION)
TABLE 31 ROE: GENETIC TOXICOLOGY TESTING MARKET, BY APPLICATION, 2018–2025 (USD MILLION)
8.5 ASIA PACIFIC
8.5.1 INCREASING RESEARCH FUNDING AND GROWING AWARENESS ABOUT PERSONALIZED THERAPEUTICS TO SUPPORT MARKET GROWTH
TABLE 32 ASIA PACIFIC: GENETIC TOXICOLOGY TESTING MARKET, BY PRODUCT, 2018–2025 (USD MILLION)
TABLE 33 ASIA PACIFIC: GENETIC TOXICOLOGY TESTING MARKET, BY APPLICATION, 2018–2025 (USD MILLION)
8.6 LATIN AMERICA
8.6.1 GROWTH IN PHARMACEUTICAL INDUSTRY IN MEXICO TO SUPPORT MARKET GROWTH
TABLE 34 LATIN AMERICA: GENETIC TOXICOLOGY TESTING MARKET, BY PRODUCT, 2018–2025 (USD MILLION)
TABLE 35 LATIN AMERICA: GENETIC TOXICOLOGY TESTING MARKET, BY APPLICATION, 2018–2025 (USD MILLION)
8.7 MIDDLE EAST & AFRICA
8.7.1 IMPROVING FOCUS ON PRECISION MEDICINE AND DISEASE GENETICS DRIVING MARKET GROWTH
TABLE 36 MIDDLE EAST & AFRICA: GENETIC TOXICOLOGY TESTING MARKET, BY PRODUCT, 2018–2025 (USD MILLION)
TABLE 37 MIDDLE EAST & AFRICA: GENETIC TOXICOLOGY TESTING MARKET, BY APPLICATION, 2018–2025 (USD MILLION)
9 COMPETITIVE LANDSCAPE
9.1 OVERVIEW
FIGURE 24 PRODUCT LAUNCHES—KEY GROWTH STRATEGY ADOPTED BY MARKET PLAYERS FROM 2017 TO NOVEMBER 2020
9.2 MARKET SHARE ANALYSIS
FIGURE 25 GENETIC TOXICOLOGY SERVICES MARKET SHARE, BY KEY PLAYER, 2019
9.3 COMPANY EVALUATION MATRIX
9.3.1 STAR
9.3.2 EMERGING LEADER
9.3.3 PERVASIVE
9.3.4 EMERGING COMPANIES
FIGURE 26 GENETIC TOXICOLOGY SERVICES MARKET: COMPETITIVE LEADERSHIP MAPPING (2019)
9.4 COMPETITIVE SITUATION AND TRENDS
9.4.1 EXPANSIONS
TABLE 38 EXPANSIONS, 2017–2020
9.4.2 ACQUISITIONS
TABLE 39 ACQUISITIONS, 2017–2020
9.4.3 OTHER STRATEGIES
TABLE 40 OTHER STRATEGIES, 2017–2020
10 COMPANY PROFILES
10.1 THERMO FISHER SCIENTIFIC INC.
FIGURE 27 THERMO FISHER SCIENTIFIC INC.: COMPANY SNAPSHOT (2019)
10.2 CHARLES RIVER LABORATORIES INTERNATIONAL, INC.
FIGURE 28 CHARLES RIVER LABORATORIES INTERNATIONAL, INC.: COMPANY SNAPSHOT (2019)
10.3 CREATIVE BIOARRAY
10.4 CYPROTEX PLC
FIGURE 29 EVOTEC AG: COMPANY SNAPSHOT (2019)
10.5 LABORATORY CORP OF AMERICA HOLDINGS
FIGURE 30 LABORATORY CORP OF AMERICA HOLDINGS: COMPANY SNAPSHOT (2019)
10.6 JUBILANT LIFE SCIENCES LIMITED
FIGURE 31 JUBILANT LIFE SCIENCES LIMITED: COMPANY SNAPSHOT (2020)
10.7 MERCK KGAA (MILLIPORE SIGMA )
FIGURE 32 MERCK KGAA: COMPANY SNAPSHOT (2019)
10.8 SHANGHAI MEDICILON INC.
10.9 EUROFINS SCIENTIFIC
FIGURE 33 EUROFINS SCIENTIFIC: COMPANY SNAPSHOT (2019)
10.10 CREATIVE BIOLABS
10.11 TOXIKON CORPORATION
10.12 ENVIRONMENTAL BIO-DETECTION PRODUCTS INC. (EBPI)
10.13 GENTRONIX LIMITED
10.14 MB RESEARCH LABORATORIES
10.15 SOTERA HEALTH LLC
11 APPENDIX
11.1 INSIGHTS OF INDUSTRY EXPERTS
11.2 DISCUSSION GUIDE
11.3 KNOWLEDGE STORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL
11.4 AVAILABLE CUSTOMIZATIONS
11.5 RELATED REPORTS
11.6 AUTHOR DETAILS
LIST OF TABLES
TABLE 1 GENETIC TOXICOLOGY SERVICES MARKET: IMPACT ANALYSIS
TABLE 2 REGULATORY AUTHORITIES OVERSEEING USE OF ANIMAL MODELS IN RESEARCH ACTIVITIES
TABLE 3 GENETIC TOXICOLOGY TESTING MARKET, BY PRODUCT, 2018–2025 (USD MILLION)
TABLE 4 GENETIC TOXICOLOGY SERVICES MARKET, BY COUNTRY, 2018–2025 (USD MILLION)
TABLE 5 GENETIC TOXICOLOGY REAGENTS AND CONSUMABLES MARKET, BY COUNTRY, 2018–2025 (USD MILLION)
TABLE 6 GENETIC TOXICOLOGY ASSAYS MARKET, BY COUNTRY, 2018–2025 (USD MILLION)
TABLE 7 GENETIC TOXICOLOGY TESTING MARKET, BY APPLICATION, 2018–2025 (USD MILLION)
TABLE 8 GENETIC TOXICOLOGY TESTING MARKET FOR HEALTHCARE INDUSTRY, BY COUNTRY, 2018–2025 (USD MILLION)
TABLE 9 GENETIC TOXICOLOGY TESTING MARKET FOR FOOD INDUSTRY, BY COUNTRY, 2018–2025 (USD MILLION)
TABLE 10 GENETIC TOXICOLOGY TESTING MARKET FOR COSMETICS INDUSTRY, BY COUNTRY, 2018–2025 (USD MILLION)
TABLE 11 GENETIC TOXICOLOGY TESTING MARKET FOR OTHER INDUSTRIES, BY COUNTRY, 2018–2025 (USD MILLION)
TABLE 12 GENETIC TOXICOLOGY TESTING MARKET, BY REGION, 2018–2025 (USD MILLION)
TABLE 13 NORTH AMERICA: GENETIC TOXICOLOGY TESTING MARKET, BY COUNTRY, 2018–2025 (USD MILLION)
TABLE 14 NORTH AMERICA: GENETIC TOXICOLOGY TESTING MARKET, BY PRODUCT, 2018–2025 (USD MILLION)
TABLE 15 NORTH AMERICA: GENETIC TOXICOLOGY TESTING MARKET, BY APPLICATION, 2018–2025 (USD MILLION)
TABLE 16 US: NIH BUDGET FOR VARIOUS DISCIPLINES, FY 2019 VS. FY 2020 (USD BILLION)
TABLE 17 US: GENETIC TOXICOLOGY TESTING MARKET, BY PRODUCT, 2018–2025 (USD MILLION)
TABLE 18 US: GENETIC TOXICOLOGY TESTING MARKET, BY APPLICATION, 2018–2025 (USD MILLION)
TABLE 19 CANADA: GENETIC TOXICOLOGY TESTING MARKET, BY PRODUCT, 2018–2025 (USD MILLION)
TABLE 20 CANADA: GENETIC TOXICOLOGY TESTING MARKET, BY APPLICATION, 2018–2025 (USD MILLION)
TABLE 21 EUROPE: GENETIC TOXICOLOGY TESTING MARKET, BY COUNTRY, 2018–2025 (USD MILLION)
TABLE 22 EUROPE: GENETIC TOXICOLOGY TESTING MARKET, BY PRODUCT, 2018–2025 (USD MILLION)
TABLE 23 EUROPE: GENETIC TOXICOLOGY TESTING MARKET, BY APPLICATION, 2018–2025 (USD MILLION)
TABLE 24 GERMANY: GENETIC TOXICOLOGY TESTING MARKET, BY PRODUCT, 2018–2025 (USD MILLION)
TABLE 25 GERMANY: GENETIC TOXICOLOGY TESTING MARKET, BY APPLICATION, 2018–2025 (USD MILLION)
TABLE 26 FRANCE: GENETIC TOXICOLOGY TESTING MARKET, BY PRODUCT, 2018–2025 (USD MILLION)
TABLE 27 FRANCE: GENETIC TOXICOLOGY TESTING MARKET, BY APPLICATION, 2018–2025 (USD MILLION)
TABLE 28 UK: GENETIC TOXICOLOGY TESTING MARKET, BY PRODUCT, 2018–2025 (USD MILLION)
TABLE 29 UK: GENETIC TOXICOLOGY TESTING MARKET, BY APPLICATION, 2018–2025 (USD MILLION)
TABLE 30 ROE: GENETIC TOXICOLOGY TESTING MARKET, BY PRODUCT, 2018–2025 (USD MILLION)
TABLE 31 ROE: GENETIC TOXICOLOGY TESTING MARKET, BY APPLICATION, 2018–2025 (USD MILLION)
TABLE 32 ASIA PACIFIC: GENETIC TOXICOLOGY TESTING MARKET, BY PRODUCT, 2018–2025 (USD MILLION)
TABLE 33 ASIA PACIFIC: GENETIC TOXICOLOGY TESTING MARKET, BY APPLICATION, 2018–2025 (USD MILLION)
TABLE 34 LATIN AMERICA: GENETIC TOXICOLOGY TESTING MARKET, BY PRODUCT, 2018–2025 (USD MILLION)
TABLE 35 LATIN AMERICA: GENETIC TOXICOLOGY TESTING MARKET, BY APPLICATION, 2018–2025 (USD MILLION)
TABLE 36 MIDDLE EAST & AFRICA: GENETIC TOXICOLOGY TESTING MARKET, BY PRODUCT, 2018–2025 (USD MILLION)
TABLE 37 MIDDLE EAST & AFRICA: GENETIC TOXICOLOGY TESTING MARKET, BY APPLICATION, 2018–2025 (USD MILLION)
TABLE 38 EXPANSIONS, 2017–2020
TABLE 39 ACQUISITIONS, 2017–2020
TABLE 40 OTHER STRATEGIES, 2017–2020
LIST OF FIGURES
FIGURE 1 GENETIC TOXICOLOGY TESTING MARKET
FIGURE 2 RESEARCH DESIGN
FIGURE 3 BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION, AND REGION
FIGURE 4 MARKET SIZE ESTIMATION: REVENUE SHARE ANALYSIS
FIGURE 5 MARKET ANALYSIS APPROACH
FIGURE 6 TOP-DOWN APPROACH
FIGURE 7 DATA TRIANGULATION METHODOLOGY
FIGURE 8 GENETIC TOXICOLOGY TESTING MARKET, BY PRODUCT, 2020 VS. 2025 (USD MILLION)
FIGURE 9 GENETIC TOXICOLOGY TESTING MARKET, BY APPLICATION, 2020 VS. 2025 (USD MILLION)
FIGURE 10 GEOGRAPHIC ANALYSIS: GENETIC TOXICOLOGY TESTING MARKET
FIGURE 11 INCREASING RESEARCH BEING CONDUCTED USING GENE-BASED TECHNOLOGIES TO DRIVE MARKET GROWTH
FIGURE 12 SERVICES SEGMENT ACCOUNTED FOR LARGEST SHARE OF EUROPEAN GENETIC TOXICOLOGY TESTING MARKET IN 2019
FIGURE 13 MARKET IN ASIA PACIFIC TO WITNESS HIGHEST GROWTH DURING
FORECAST PERIOD
FIGURE 14 NORTH AMERICA TO CONTINUE DOMINATING GENETIC TOXICOLOGY TESTING MARKET UNTIL 2025
FIGURE 15 R&D INVESTMENTS, BY COUNTRY, 2017 VS. 2018 (USD BILLION)
FIGURE 16 SUPPLY CHAIN ANALYSIS: IN VITRO TOXICOLOGY TESTING MARKET
FIGURE 17 GLOBAL PROPAGATION OF COVID-19
FIGURE 18 COVID-19 PROPAGATION: SELECT COUNTRIES
FIGURE 19 SERVICES SEGMENT TO LEAD GENETIC TOXICOLOGY TESTING MARKET DURING FORECAST PERIOD
FIGURE 20 HEALTHCARE INDUSTRY TO ACCOUNT FOR LARGEST MARKET SIZE DURING FORECAST PERIOD
FIGURE 21 TOTAL NUMBER OF CLINICAL TRIALS: GLOBAL VS. NORTH AMERICA, 2017
FIGURE 22 NORTH AMERICA: GENETIC TOXICOLOGY TESTING MARKET SNAPSHOT
FIGURE 23 EUROPE: GENETIC TOXICOLOGY TESTING MARKET SNAPSHOT
FIGURE 24 PRODUCT LAUNCHES—KEY GROWTH STRATEGY ADOPTED BY MARKET PLAYERS FROM 2017 TO NOVEMBER 2020
FIGURE 25 GENETIC TOXICOLOGY SERVICES MARKET SHARE, BY KEY PLAYER, 2019
FIGURE 26 GENETIC TOXICOLOGY SERVICES MARKET: COMPETITIVE LEADERSHIP
MAPPING (2019)
FIGURE 27 THERMO FISHER SCIENTIFIC INC.: COMPANY SNAPSHOT (2019)
FIGURE 28 CHARLES RIVER LABORATORIES INTERNATIONAL, INC.: COMPANY
SNAPSHOT (2019)
FIGURE 29 EVOTEC AG: COMPANY SNAPSHOT (2019)
FIGURE 30 LABORATORY CORP OF AMERICA HOLDINGS: COMPANY SNAPSHOT (2019)
FIGURE 31 JUBILANT LIFE SCIENCES LIMITED: COMPANY SNAPSHOT (2020)
FIGURE 32 MERCK KGAA: COMPANY SNAPSHOT (2019)
FIGURE 33 EUROFINS SCIENTIFIC: COMPANY SNAPSHOT (2019)
